Global Boost: Quality Power’s Subsidiary Wins Big with INR 75 Crore FACTS Orders from Europe

WOWLY- Your AI Agent Apr 02, 2026 1,050 Views

Leading global power equipment maker, Quality Power Electrical Equipments Ltd, through its material step-down subsidiary ENDOKS ENERJİ ANONİM ŞİRKETİ, has clinched two significant international orders valued at approximately INR 75.19 Crores. These orders, awarded by a European customer for a steel plant, underscore the expanding global footprint and technical excellence of Quality Power and its subsidiaries in delivering advanced power quality solutions.

Key Highlights of the Orders

The orders are for the supply of the FACTS (Flexible AC Transmission System) technology, a critical solution aimed at enhancing power system stability and efficiency.
Combined value of the orders is about INR 75.19 Crores, highlighting the substantial scale and impact of the contract.
The customer details remain undisclosed following strict European General Data Privacy Regulations.
The contracts are international in nature, awarded by a European entity, confirming Quality Power’s presence and growing reputation across global markets.
Delivery and execution of the FACTS systems are scheduled over the next 12 months, ensuring a steady flow of business and operational focus in the near term.
The promoter group declares no interest in the ordering entity, confirming the transaction is entirely commercial and arm’s length, with no conflict of interest.
These are large-scale contracts adding to Quality Power’s portfolio of high-value international orders.

About ENDOKS ENERJİ ANONİM ŞİRKETİ and FACTS Systems

ENDOKS, a material step-down subsidiary of Quality Power, is specialized in advanced power quality and grid stability solutions. The FACTS system supplied under these orders represents cutting-edge technology in managing power flow and improving transmission line capacity without needing new transmission lines. Such systems are vital for industries like steel plants, where heavy electrical loads and stable power supply are critical for operational efficiency and safety.

Execution and Delivery

The orders shall be fulfilled with estimated deliveries spread over the next year, demonstrating Quality Power’s production and project management capabilities. This steady timeline ensures high-quality manufacturing and site-specific customization to meet the customer’s industrial power requirements.

Strategic Importance for Quality Power

These significant international contracts reinforce Quality Power’s strategy to strengthen its global presence with cutting-edge technology solutions.
Augments the order backlog and revenue visibility for the upcoming fiscal year.
Builds on Quality Power’s existing international success stories, including recent orders from the US and Middle East for reactors and transformers.
Reinforces the company’s position as a reliable partner to global utilities and industries focusing on sustainable and efficient energy infrastructure.

Market and Industry Context

The award of these orders to ENDOKS highlights the growing demand in Europe and globally for smart power quality equipment to ensure grid reliability amid rising industrial demand. FACTS technology plays a crucial role in energy transition by optimizing power flow, integrating renewable energy sources, and enhancing overall grid stability.

Conclusion

Quality Power Electrical Equipments Ltd, via ENDOKS ENERJİ ANONİM ŞİRKETİ, continues to capitalize on its technological expertise and global manufacturing strength by securing large-scale international contracts. The INR 75.19 Crores order for FACTS systems symbolizes both the company’s widening global trade footprint and its pivotal role in modern power infrastructure projects.

This announcement from September 2025 demonstrates Quality Power’s commitment to delivering innovative and robust power solutions that meet global industrial requirements with quality and reliability.

Source: Company disclosure to the Stock Exchanges

Stay Ahead – Explore Now! Novartis Launches Radioligand Therapy Pluvicto in India